Vowst由Seres (MCRB)与雀巢健康科学(nestle Health Science)合作开发,于2023年获得FDA批准,成为首个用...查看全文
Seres Therapeutics(MCRB)05-08 19:15
$Seres Therapeutics(MCRB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-133766 Act: 34 Size: 240 KB 网页链接查看全文
Seres Therapeutics(MCRB)05-18 08:25
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062058 Size: 9 KB 网页链接查看全文
Seres Therapeutics(MCRB)05-18 08:25
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062057 Size: 9 KB 网页链接查看全文
JZee2023-04-27 14:10
$赛里斯治疗(MCRB)$ 的口服翔获批了,用于治疗复发的艰难梭菌感染。美国每年复发艰难梭菌感染人数约十五万,看高一点算20%渗透。定价目前还没出来,和辉凌的非口服的翔做个比较的话,大概定价五千到一万美元还是可以的。粗算能卖两三亿美元?接着看竞争形态。竞品1,$辉瑞(PFE)$ 的艰难梭菌疫苗,...查看全文
joe88772023-04-27 08:19
$赛里斯治疗(MCRB)$ Seres Therapeutics and Nestl Health Science Announce FDA Approval of VOWSTTM (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial Treatment for Recurrent CDI查看全文
牛唐2023-04-25 21:53
医药板块速评(2023.04.22)
1、$In8bio(INAB)翻倍,谁有潜力成为下一个?
2、$赛里斯治疗(MCRB)$ 上市审批在即,是否有配置机会?
3、$蔚来-SW(09866)$ 、$Coinbase Global(COIN)$ 、$雾芯科技(RLX)、$VMware(VMW)、$斯普林特(S)期权异动,后续走势如何看?查看全文
jincen02082022-05-27 07:15
#生物医药科技笔记##医药创新#
2022年5月26日 Flagship以7500万美元投资孵化出ProFound Therapeutics公司,将探索一批新蛋白靶点;
1、Flagship Pioneering是一家著名生物医疗风投机构以及初创企业孵化器,其中孵化了包括Moderna、Seres Therapeutics、Rubius等知名公司,其中Moderna因疫...查看全文
joe88772022-01-20 16:08
$赛里斯治疗(MCRB)$ New England Journal of Medicine Publishes Data from ECOSPOR lll Phase 3 Study Evaluating Investigational Microbiome Therapeutic SER-109 in Recurrent C. Difficile Infection查看全文
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081521 Size: 5 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081522 Size: 5 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-081527 Size: 5 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062052 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062056 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062059 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062057 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062058 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-062061 Size: 9 KB 网页链接
$Seres Therapeutics(MCRB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-055159 Act: 34 Size: 10 MB 网页链接